In a bold and provocative prediction, Dario Amodei — the CEO of leading AI research company Anthropic — claims that artificial intelligence could enable humans to double their lifespans by 2035, potentially transforming how we understand aging, medicine, and even mortality itself by compressing a century’s worth of biological discoveries into just the next decade.
According to Amodei, AI models are rapidly evolving beyond data processing and language tasks, now demonstrating capabilities in drug discovery, genetic mapping, and disease modeling that could revolutionize longevity science by identifying cures, reversing cellular aging, and optimizing personal health in ways previously unimaginable.
He envisions a future where machine learning algorithms simulate trillions of biological experiments at lightning speed, drastically reducing the cost and time needed to develop age-delaying therapies, thereby democratizing access to life-extending technologies and reshaping global healthcare systems.
While critics have labeled his claims as overly ambitious or even bordering on science fiction, Amodei insists that the trajectory of AI innovation — particularly in fields like protein folding, DNA editing, and personalized medicine — supports his optimism, pointing to ongoing breakthroughs where AI already outpaces traditional research methods.
If these advancements continue at their current pace, we may be on the cusp of a profound societal shift where longevity isn’t just a luxury of the wealthy or a dream of futurists, but a scalable, science-driven reality powered by algorithms — one in which living to 120 or beyond becomes not only possible, but increasingly normal, rewriting humanity’s biological timeline with code instead of chemistry.
